COVID-19 vaccination rates in the U.S. are declining, with only 23% of adults vaccinated in the 2024-25 season. Conflicting government recommendations under the Trump administration and misinformation contribute to hesitancy, particularly among Hispanic and Black communities. The FDA and CDC have narrowed vaccine recommendations, while some states impose barriers to access. Experts emphasize the importance…

Patrick Byrne’s book “Danger Close” reveals a significant breach in the VA medical systems, allegedly orchestrated by foreign adversaries. The cyberattack compromised critical areas such as diagnostic imaging, pharmaceutical records, and sensitive patient data, posing a severe threat to national security and patient safety. The breach was reportedly facilitated by a VA employee who created…

The Senate Finance Committee has advanced Thomas March Bell, a Trump-aligned nominee, for the role of inspector general at the Department of Health and Human Services (HHS). Bell’s nomination, which has raised concerns about his independence due to his strong ties to President Trump and the Republican Party, now moves to the full Senate for…

Pressure injuries are a silent cost escalator. They increase morbidity, prolong stays, and drain budgets. Yet most are preventable. The real challenge is operational consistency: ensuring every patient is repositioned at the right time, every time. That is where wearable repositioning sensors are shifting the cost-quality equation. Systems like the LEAF Patient Monitoring System give…

President Trump’s executive order, ‘Preventing Woke AI in the Federal Government Act,’ aims to eliminate diversity, equity, and inclusion considerations in federal AI systems. This policy threatens to undermine efforts to address systemic biases in healthcare algorithms, potentially endangering marginalized communities. The order could halt advancements in creating equity-centered AI tools that aim to rectify…

Dr. Robert R. Redfield emphasizes the need for a coordinated national response to the Alzheimer’s crisis, drawing parallels to the HIV/AIDS epidemic. With Alzheimer’s cases expected to double by 2050, early diagnosis and intervention are crucial. Recent advancements, including FDA-approved blood tests and anti-amyloid therapies, offer new opportunities for early-stage treatment. Redfield advocates for policy…